A number of firms have modified their ratings and price targets on shares of GAP (NYSE: GAP) recently: 1/7/2026 – GAP was upgraded by analysts at UBS Group AG from a “neutral” rating to a “buy” rating. They now have a $41.00 price target on the stock, up previously from $26.00. 1/6/2026 – GAP had […]

Several brokerages have updated their recommendations and price targets on shares of Five Below (NASDAQ: FIVE) in the last few weeks: 1/13/2026 – Five Below was given a new $255.00 price target on by analysts at UBS Group AG. 1/13/2026 – Five Below had its price target raised by analysts at Wells Fargo & Company […]

A number of firms have modified their ratings and price targets on shares of CoreWeave (NASDAQ: CRWV) recently: 1/12/2026 – CoreWeave had its price target lowered by analysts at Barclays PLC from $120.00 to $90.00. They now have an “equal weight” rating on the stock. 1/12/2026 – CoreWeave is now covered by analysts at The […]

Several analysts have recently updated their ratings and price targets for Planet Labs PBC (NYSE: PL): 1/13/2026 – Planet Labs PBC was given a new $26.00 price target on by analysts at Morgan Stanley. 1/13/2026 – Planet Labs PBC had its “buy” rating reaffirmed by analysts at Craig Hallum. They now have a $30.00 price […]

Stoke Therapeutics (NASDAQ: STOK) recently received a number of ratings updates from brokerages and research firms: 1/12/2026 – Stoke Therapeutics had its price target raised by analysts at Wedbush from $32.00 to $36.00. They now have an “outperform” rating on the stock. 1/5/2026 – Stoke Therapeutics had its price target raised by analysts at Canaccord […]

Arrowhead Pharmaceuticals (NASDAQ: ARWR) recently received a number of ratings updates from brokerages and research firms: 1/13/2026 – Arrowhead Pharmaceuticals had its “overweight” rating reaffirmed by analysts at Piper Sandler. They now have a $110.00 price target on the stock, up previously from $100.00. 1/7/2026 – Arrowhead Pharmaceuticals had its price target raised by analysts […]

Equitable (NYSE: EQH) has recently received a number of price target changes and ratings updates: 1/13/2026 – Equitable had its price target lowered by analysts at Wells Fargo & Company from $62.00 to $60.00. They now have an “overweight” rating on the stock. 1/8/2026 – Equitable was given a new $58.00 price target on by […]

Arrowhead Pharmaceuticals (NASDAQ:ARWR – Get Free Report)‘s stock had its “overweight” rating reiterated by research analysts at Piper Sandler in a research note issued to investors on Tuesday,Benzinga reports. They presently have a $110.00 target price on the biotechnology company’s stock, up from their prior target price of $100.00. Piper Sandler’s price objective points to […]

Equities Research Analysts’ price target changes for Tuesday, January 13th: Ag Growth International (TSE:AFN) had its target price increased by Royal Bank Of Canada from C$25.00 to C$30.00. They currently have a sector perform rating on the stock. Ag Growth International (TSE:AFN) was given a C$41.00 price target by analysts at TD Securities. The firm […]